top of page

Exscientia's CEO shares a pipeline overview and learnings from being one of the first AI companies out front and to go public

Dave Hallett gives an overview of Exscientia and describes how important testing compounds in the company's labs has been to its iterative process that is founded in AI.



Comments


Join the BiotechTV mailing list

Thanks for subscribing!

bottom of page